Pa317 retrovirus packaging cells

Molecular Therapy

Volumn 6, Issue 5, 2002, Pages 572-575

  Miller, A Dusty ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DNA; GAG PROTEIN; RETROVIRUS VECTOR; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL STRAIN; COMBINED IMMUNODEFICIENCY; DEATH; DNA PACKAGING; DNA TRANSFECTION; ENZYME DEFICIENCY; GENE THERAPY; GENE TRANSFER; GENETIC RECOMBINATION; HELPER VIRUS; HOST CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; LYMPHOMA; MOLONEY LEUKEMIA ONCOVIRUS; MONKEY; NONHUMAN; POLYADENYLATION; RETROVIRUS; SAFETY; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENETICS; VIRION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; CELL LINE; CLINICAL TRIAL; GENETICS; HISTORY;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; ONCOVIRINAE; RNA VIRUSES; SIMIAE; SIMIAN VIRUS 40; UNIDENTIFIED RETROVIRUS;

ANIMALS; CELL LINE; CLINICAL TRIALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HISTORY, 20TH CENTURY; HUMANS; RETROVIRIDAE;

EID: 0036853003     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(02)90728-8     Document Type: Article

References (24)

1. Miller, A. D., and Buttimore, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6: 2895-2902.
2. Rosenberg, S. A., et al. (1990). Gene transfer into humans - immunotheraphy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323: 570-578.
3. Blaese, R. M., et al. (1995). T lymphocyte -directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270: 475-480.
4. Mann, R., Mulligan, R. C., and Baltimore, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free detective retrovirus. Cell 33: 153-159.
5. Cone, R. D., and Mulligan, R. C. (1984). High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. USA 81: 6349-6353.
6. Miller, A. D., Law, M. F., and Verma, I. M. (1985). Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5: 431-437.
7. Armentano, D., et al. (1987). Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61: 1647-1650.
8. Bender, M. A., Palmer, T. D., Gelinas, R. E., and Miller, A. D. (1987). Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61: 1639-1646.
9. Hock, R. A., Miller, A. D., and Osborne, W. R. A. (1989). Expression of human adenosine deaminae from various strong promoters after gene into human hematopoietic cell lines. Blood 74: 876-881.
10. Miller, A. D., and Rosman, G. J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-990.
11. Cornetta, K., et al. (1990). Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum. Gene Ther. 1: 15-30.
12. Kantoff, P. W., et al. (1987). Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J. Exp. Med. 166: 219-234.
13. Palmer, T. D., Hock, R. A., Osborne, W.R.A., and Miller, A. D. (1991). Genetically modified skin fibroblast persist long after transplantation bit gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 84: 1055-1059.
14. Palmer, T. D., Rosman, G. J., Osborne, W. R. A., and Miller, A. D. (1991). Genetically modified skin fibroblast persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88: 1330-1334.
15. Shand, N., et al. (1999). A phase 1-2 trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. Hum. Gene Ther. 10: 2325-2335.
16. Rainov, N. G., et al. (2000). A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11: 2389-2401.
17. Otto, E., et al. (1994). Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequence. Hum. Gene Ther. 5: 567-575.
18. Cornetta, K., et al. (1991). No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Hum. Gene Ther. 2: 215-219.
19. Donahue, R.E, et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176: 1125-1135.
20. Chong, H., and Vile, R. G. (1998). A replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line. Gene Ther. 3: 624-629.
21. Chong, H., Starkey, W., and Vile, R. G. (1998). A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J. Virol. 72: 2663-2670.
22. Miller, A. D., et al. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 5: 2220-2224.
23. Danos, O., and Mulligan, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85: 6460-6464.
24. Brenner, M. (2002). Evidence-based regulation - a personal review. Mol. Ther. 6: 137.